HP and irritable bowel syndrome: The lack of statistically significant change after the intervention may result from high interindividual variability, the multifactorial nature of IBS, or the limited specificity and sensitivity of current ELISA-based assays for fecal zonulin, underscoring the need for multi-marker approaches in gut barrier assessment (18).